Search Results 451-460 of 19282 for Myocardium

1. A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis - Mayo Clinic

   Myocardial infarction. Major surgery performed within the next 3 months; Time period > 12 weeks between last drug intake in 1199.214 and Visit 2 of this ...

2. Feasibility Study of a Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation - Mayo Clinic

   Myocardial infarction in the past 3 months; Cerebral embolism, stroke, or TIA in past 3 months; Absence of a defined left atrial appendage on echocardiogram ...

3. A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD - Mayo Clinic

   ... myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR). Participation eligibility. Participant eligibility ...

4. Paclitaxel-Coated Pulmonary Balloon For The Treatment Of Benign Central Airway Stenosis - Mayo Clinic

   ... myocardial infarction, severe pulmonary disease, bleeding diathesis, large thoracic aneurysm, pharyngeal or cervical deformity, ongoing infection, etc 19.

5. Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer - Mayo Clinic

   Has a clinically significant cardiovascular disease such as unstable angina, myocardial infarction, or acute coronary syndrome within ≤180 days prior to ...

6. A Study to Evaluate 9-ING-41 As a Single Agent or in Combination with Ruxolitinib in Myelofibrosis Patients - Mayo Clinic

   Has had a myocardial infarction within 12 weeks of the first dose of 9-ING-41. Has any medical and/or social condition which, in the opinion of the ...

7. NMARQ™ Pulmonary Vein Isolation System For The Treatment Of Paroxysmal Atrial Fibrillation - Mayo Clinic

   Myocardial infarction within the previous 60 days (2 months). Left ventricular ejection fraction <40%. History of blood clotting or bleeding abnormalities ...

8. A Study Of Organoids For Hypoxia-Induced Dysfunction In Hypertrophic Cardiomyopathy - Mayo Clinic

   The purpose of this study is to develop an in vitro cardiac organoid model representative of hypertrophic cardiomyopathy from myectomy-derived myocardial tissue ...

9. SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Chronic Myelomonocytic Leukemia) - Mayo Clinic

   ... myocardial infarction, unstable angina, or stroke within 6 months prior to study entry, uncontrolled hypertension or clinically significant arrhythmias not ...

10. Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer - Mayo Clinic

    ... myocardial infarction (MI) in last 3 months, or unstable angina pectoris, significant uncontrolled cardiac arrhythmia, liver cirrhosis, interstitial lung ...